ArticleClinical epigenetics2026

Correction: GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

Janina Müller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.